Cognitive, Behavioral, and Functional Change in Behavioral Variant Frontotemporal Dementia (bvFTD)
Completed
Conditions studied: Frontotemporal Dementia, Behavioral Variant Frontotemporal Dementia
In brief
The objectives of the study are to; (1) estimate the change in disease -related cognitive decline over 1 year on a battery of cognitive tests administered to participants with early-stage symptomatic Behavioral Variant Frontotemporal Dementia (bvFTD) phenotypic variant; (2) identify the cognitive test or brief battery of cognitive tests which are the most sensitive to detect bvFTD progression; (3) determine the optimal schedule of administration of cognitive tests to detect bvFTD progression; (4) evaluate the relationship between cognitive tests and measures of behavior, function, caregiver's burden, quality of life (QOL); and (5) obtain blood samples for genetic and exploratory biomarkers correlations.
Key facts
- Study ID
- NCT03088956
- Run by
- Biogen
- People needed
- 47
- Starts
- 2018-01-19
- Expected to finish
- 2019-09-23
- Last updated by the study team
- 2020-06-16
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.
Where it is running
- Research Site — Birmingham, Alabama, United States
- Research Site — Los Angeles, California, United States
- Research Site — Boca Raton, Florida, United States
- Research Site — Boca Raton, Florida, United States
- Research Site — Atlanta, Georgia, United States
- Research Site — Elk Grove Village, Illinois, United States
- Research Site — Baltimore, Maryland, United States
- Research Site — Rochester, Minnesota, United States
- Research Site — Columbus, Ohio, United States
- Research Site — Philadelphia, Pennsylvania, United States
- Research Site — Knoxville, Tennessee, United States
- Research Site — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.